Vishal Gupta to Antigens, CD19
This is a "connection" page, showing publications Vishal Gupta has written about Antigens, CD19.
Connection Strength
0.058
-
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL. J Clin Oncol. 2025 Feb 10; 43(5):558-566.
Score: 0.058